| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.31B | 46.09B | 39.16B | 34.48B | 30.43B | 24.85B |
| Gross Profit | 39.63B | 42.25B | 35.60B | 31.16B | 27.48B | 22.49B |
| EBITDA | 11.50B | 12.15B | 9.75B | 8.88B | 7.62B | 6.33B |
| Net Income | 7.01B | 8.40B | 5.61B | 5.98B | 5.03B | 3.88B |
Balance Sheet | ||||||
| Total Assets | 26.29B | 30.89B | 26.01B | 23.52B | 22.08B | 18.93B |
| Cash, Cash Equivalents and Short-Term Investments | 18.09B | 23.31B | 19.05B | 16.77B | 14.88B | 12.93B |
| Total Debt | 0.00 | 0.00 | 307.00M | 353.00M | 449.00M | 2.00M |
| Total Liabilities | 7.82B | 8.55B | 7.92B | 6.30B | 6.50B | 5.57B |
| Stockholders Equity | 18.47B | 22.34B | 18.09B | 17.22B | 15.59B | 13.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.39B | 7.93B | 6.93B | 5.60B | 5.06B |
| Operating Cash Flow | 0.00 | 9.57B | 8.12B | 7.09B | 5.91B | 5.09B |
| Investing Cash Flow | 0.00 | -8.78B | -607.00M | -461.00M | -944.00M | -436.00M |
| Financing Cash Flow | 0.00 | -4.61B | -5.31B | -4.84B | -3.17B | -5.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥251.43B | 16.33 | 28.98% | 5.57% | 4.09% | 17.10% | |
79 Outperform | ¥118.19B | 13.47 | ― | 7.51% | 8.28% | -36.32% | |
75 Outperform | ¥139.85B | 20.10 | ― | 2.38% | 20.17% | 32.32% | |
73 Outperform | ¥9.40T | 21.38 | 27.29% | 0.27% | 1.23% | 26.94% | |
66 Neutral | ¥529.90B | 15.57 | 19.18% | 3.59% | 6.95% | 13.63% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
42 Neutral | ¥71.79B | -1,275.30 | -6.02% | 0.77% | -9.70% | -108.59% |